Sweden · Delayed Price · Currency is SEK BioArctic AB Company Description
BioArctic AB (publ) develops biological drugs for patients with central nervous system disorders in Sweden.
It engages in the research and development of biological drugs, such as antibodies that address high unmet medical needs.
The company’s therapeutic areas encompass neurodegenerative disorders, such as Alzheimer’s disease, Parkinson’s disease, and other ALS diseases.
In addition, it offers Lecanemab for intravenous treatment. Further, it is developing Lecanemab for Subcutaneous treatment, which is in registration stage; lecanemab, which is in phase 3 clinical trials for presymptomatic treatment; Exidavnemab, which is in phase 2 clinical trials; Lecanemab back-up, BAN2803, ND3014, and BAN2802 that are in preclinical trials; and ND-BT8825, HD-BT4801, GD-BT6822, ND-BT3814, PD-BT2238 which are in research stage.
The company was formerly known as BioArctic Neuroscience AB and changed its name to BioArctic AB (publ) in 2016.
BioArctic AB (publ) was incorporated in 2000 and is based in Stockholm, Sweden.
| Country | Sweden |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 129 |
| CEO | Gunilla Osswald |
Contact Details
Address: Warfvinges vag 35 Stockholm, 112 51 Sweden | |
| Phone | 46 86 95 69 30 |
| Website | bioarctic.se |
Stock Details
| Ticker Symbol | BIOA.B |
| Exchange | Nasdaq Stockholm |
| Share Class | Class B Shares |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0010323311 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Gunilla Osswald Ph.D. | President and Chief Executive Officer |
| Dr. Pär Gellerfors | Co-Founder, Senior Vice President of Business Strategy and Director |
| Prof. Lars Lannfelt | Co-Founder, Senior Vice President of Medical science and Director |
| Anders Martin-Lof M.B.A., M.Sc. | Secretary of the Board and Chief Financial Officer |
| Per-Ola Freskgard | Chief Scientific Officer |
| Oskar Bosson | Vice President and Head of IR and Communication |
| Emilie Ankarcrona Smith | General Counsel and Head of Legal and IP |
| Harald Borgeke | Head of Public Affairs |
| Frida Lekander | Head of Marketing |
| Rebecca Kastell | Vice President and Head of Human Resources |